Up to 12% of European men aged 55-69 years diagnosed with prostate cancer have high-risk disease and thus are at increased risk of mortality. There remains a lack of consensus on definitive treatment for prostate cancer, although both radiation therapy and radical prostatectomy are frequently utilized.
Furthermore, the different types of radiation and surgical options also increase the complexity of deciding on a single treatment, as does the use of multimodal treatment plans. Here, we provide an overview of radiation therapy and radical prostatectomy in treating high-risk prostate cancer.
Oncology research and treatment. 2015 Nov 16 [Epub]
Robert Qi, Judd Moul
Division of Urology, Department of Surgery and Duke Cancer Institute, Duke University Medical Center, Durham, NC, USA.